Lifen participated in the HARMON-IA project led by Pfizer and Novartis in the Cancer Filière.
Public source
Publisher name
Public post
« La collecte manuelle de données cliniques pour les études en vie réelle n'est plus le standard de référence. L'IA est en train de le devenir. » C'est l'un des messages…
Company
Lifen
Data intelligence for Healthcare Professionals.
- Industry
- Hospitals and Health Care
- Location
- Paris, FR
- Company size
- 51–200 employees
About Lifen
Streamline access, organization, and sharing of medical data to enhance the quality of care and clinical research.
See moreLatest activity
Latest activity from Lifen
15 signals
Research & Knowledge
Lifen published a new newsletter featuring the Sainte-Geneviève clinic achieving a certification from the HAS in one month and the CH Annecy Genevois automation for 2 clients.
Research & Knowledge
Lifen published a new newsletter featuring a clinical research update for the LUCC Lung Cohort, with clinical data generated by AI and officially referenced by the HAS.
Presence & Recognition
Lifen published a new newsletter featuring the community reaching 20,000 subscribers.
Discover more
Similar signals
Similar public activity from other companies.
Research & Knowledge
Vivalto Santé
Vivalto Santé is having 392 international oncology protocols in progress.
Research & Knowledge
Institut Curie
Institut Curie launched the FRATHEA project in 2025, which aims to demonstrate the efficacy and safety of the FLASH radiotherapy and launch clinical trials for patients with cancer at a particularly unfavorable prognosis.
Research & Knowledge
Pierre Fabre Oncology
Pierre Fabre Oncology conducted a project with Laboratoires Pierre Fabre and Filière Intelligence Artificielle & Cancers in NSCLC to describe the molecular testing pathway and identify factors impacting therapeutic decisions.
Research & Knowledge
IQVIA France
IQVIA France published a book titled 'Alors que l’information scientifique devient toujours plus accessible, le véritable enjeu n’est plus seulement de trouver la donnée, mais de savoir l’interpréter, la contextualiser et la traduire en décisions pertinentes pour les professionnels de santé' exploring how MSLs combine scientific expertise, human intelligence, and emerging technologies to create value.
Research & Knowledge
CHU Dijon Bourgogne